Matthew  Orlando net worth and biography

Matthew Orlando Biography and Net Worth

General Counsel of Kenvue

Matt Orlando is the General Counsel for Kenvue. In this role, Matt leads the Legal, Compliance, Privacy, Global Security and Brand Protection organizations.

Matt previously served as Corporate Secretary and Worldwide Vice President, Corporate Governance, for Johnson & Johnson, acting as a liaison to the Johnson & Johnson Board of Directors and the investment community. Partnering closely with Investor Relations as well as business and functional leadership, Matt’s responsibilities included continuing to strengthen the Company’s corporate governance practices to help drive long-term value creation and business integrity; managing a broad and robust continuum of disclosure, including the Company’s Proxy Statement and Health for Humanity Report; helping lead and launch the Company’s newly-articulated Environmental, Social and Governance strategy; and leading the Annual Shareholders Meeting and other year-round investor engagement activities.

With legal experience across Australia, Europe and the United States, Matt brings a deep understanding of the complex and rapidly-evolving global environment and an established record of leading high-performing global teams. During his more than 15 years with Johnson & Johnson, Matt held a variety of legal leadership roles, including General Counsel, Global Consumer Medical Devices, where he served on the Global Vision Leadership team; Vice President, Law for the Cardiovascular & Specialty Solutions (CSS) Group and member of the CSS Global Management Board; and regional lawyer for a number of medical device businesses.

Throughout his career, Matt has been recognized as a values-driven leader and business partner who is committed to the success of the businesses and colleagues he has served. Passionate about developing high performing talent, Matt has contributed to many talent development initiatives and sponsored several leadership and Employee Resource Groups (ERGs) across the organization. He currently serves as the executive sponsor for the South Asian Professional Network Association (SAPNA) ERG.

Prior to joining Johnson & Johnson, Matt worked for the pharmaceutical company UCB in Brussels as well as law firms in Australia. Matt obtained his law degree as well as his finance degree from Murdoch University in Australia and is admitted to practice law in the United States and Australia.

How do I contact Matthew Orlando?

The corporate mailing address for Orlando and other Kenvue executives is , , . Kenvue can also be reached via phone at (732) 524-0400 and via email at [email protected]. Learn More on Matthew Orlando's contact information.

Has Matthew Orlando been buying or selling shares of Kenvue?

During the past quarter, Matthew Orlando has sold $679,751.06 of Kenvue stock. Most recently, Matthew Orlando sold 38,491 shares of the business's stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a transaction totalling $679,751.06. Learn More on Matthew Orlando's trading history.

Who are Kenvue's active insiders?

Kenvue's insider roster includes Richard Allison, Jr. (Director), Matthew Orlando (General Counsel), and Jeffrey Smith (Director). Learn More on Kenvue's active insiders.

Are insiders buying or selling shares of Kenvue?

During the last year, Kenvue insiders bought shares 2 times. They purchased a total of 6,377,694 shares worth more than $110,971,206.42. During the last year, insiders at the sold shares 1 times. They sold a total of 38,491 shares worth more than $679,751.06. The most recent insider tranaction occured on May, 8th when General Counsel Matthew Orlando sold 38,491 shares worth more than $679,751.06. Insiders at Kenvue own 1.6% of the company. Learn More about insider trades at Kenvue.

Information on this page was last updated on 5/8/2026.

Matthew Orlando Insider Trading History at Kenvue

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/8/2026Sell38,491$17.66$679,751.06View SEC Filing Icon  
See Full Table

Matthew Orlando Buying and Selling Activity at Kenvue

This chart shows Matthew Orlando's buying and selling at Kenvue by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kenvue Company Overview

Kenvue logo
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
Read More

Today's Range

Now: $17.18
Low: $17.10
High: $17.31

50 Day Range

MA: $17.52
Low: $16.73
High: $18.41

2 Week Range

Now: $17.18
Low: $14.02
High: $24.35

Volume

23,719,051 shs

Average Volume

33,869,344 shs

Market Capitalization

$32.98 billion

P/E Ratio

20.21

Dividend Yield

4.83%

Beta

0.55